Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_3
7
100%

Phase Distribution

0

Early Stage

0

Mid Stage

7

Late Stage

Phase Distribution7 total trials
Phase 3Large-scale testing
7(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Other(7)

Detailed Status

unknown7

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 37 (100.0%)

Trials by Status

unknown7100%

Recent Activity

0 active trials
Showing 5 of 7
unknownphase_3

Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy

NCT06071988
unknownphase_3

Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain

NCT06072560
unknownphase_3

Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy

NCT06071936
unknownphase_3

Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain

NCT06071962
unknownphase_3

Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis

NCT06072001
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT06071988Phase 3

Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy

Unknown
NCT06072560Phase 3

Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain

Unknown
NCT06071936Phase 3

Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy

Unknown
NCT06071962Phase 3

Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain

Unknown
NCT06072001Phase 3

Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis

Unknown
NCT06072573Phase 3

Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy

Unknown
NCT06071975Phase 3

Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy

Unknown

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7